$782 Million is the total value of HARBOURVEST PARTNERS LLC's 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
W | Wayfair, Inc. | $201,772,000 | -25.7% | 1,062,126 | 0.0% | 25.79% | +1.2% | |
SWI | Solarwinds Corp. | $52,781,000 | -15.2% | 3,719,600 | 0.0% | 6.75% | +15.4% | |
N-Able, Inc. | $41,288,000 | -10.6% | 3,719,600 | 0.0% | 5.28% | +21.7% | ||
Omega Therapeutics, Inc. | $29,991,000 | -39.9% | 2,647,059 | 0.0% | 3.83% | -18.2% | ||
Outbrain Inc. | $22,680,000 | -5.4% | 1,620,000 | 0.0% | 2.90% | +28.7% | ||
EVLO | Evelo Biosciences, Inc. | $18,595,000 | -13.8% | 3,063,505 | 0.0% | 2.38% | +17.3% | |
FTCH | Farfetch Ltd.ordinary shares cla | $14,800,000 | -10.8% | 442,716 | 0.0% | 1.89% | +21.4% | |
BHG | Bright Health Group, Inc. | $14,509,000 | -57.8% | 4,217,715 | 0.0% | 1.85% | -42.7% | |
RUBY | Rubius Therapeutics, Inc. | $9,553,000 | -45.9% | 986,878 | 0.0% | 1.22% | -26.3% | |
RLAY | Relay Therapeutics, Inc. | $9,103,000 | -2.6% | 296,402 | 0.0% | 1.16% | +32.6% | |
AXLA | Axcella Health, Inc. | $5,869,000 | -29.9% | 2,807,981 | 0.0% | 0.75% | -4.6% | |
KLDO | Kaleido BioSciences, Inc. | $4,383,000 | -56.2% | 1,833,832 | 0.0% | 0.56% | -40.5% | |
TWLO | Twilio, Inc. | $3,837,000 | -17.5% | 14,572 | 0.0% | 0.49% | +12.1% | |
NARI | Inari Medical | $3,518,000 | +12.5% | 38,540 | 0.0% | 0.45% | +53.1% | |
ZUO | Zuora, Inc. | $3,062,000 | +12.7% | 163,894 | 0.0% | 0.39% | +53.3% | |
IBRX | ImmunityBio, Inc. | $2,041,000 | -37.6% | 335,709 | 0.0% | 0.26% | -15.0% | |
SGTX | Sigilon Therapeutics, Inc. | $2,044,000 | -51.2% | 740,740 | 0.0% | 0.26% | -33.6% | |
ONTF | ON24, Inc. | $1,895,000 | -13.0% | 109,210 | 0.0% | 0.24% | +18.0% | |
YEXT | Yext, Inc. | $1,142,000 | -17.5% | 115,147 | 0.0% | 0.15% | +12.3% | |
ROOT | Root, Inc. | $633,000 | -41.2% | 204,314 | 0.0% | 0.08% | -19.8% | |
PACB | Pacific Biosciences of California, Inc. | $480,000 | -20.0% | 23,484 | 0.0% | 0.06% | +8.9% | |
DCT | Duck Creek Technologies, Inc. | $437,000 | -31.9% | 14,508 | 0.0% | 0.06% | -6.7% | |
MCRB | Seres Therapeutics, Inc. | $411,000 | +19.5% | 49,363 | 0.0% | 0.05% | +65.6% | |
CTMX | Cytomx Therapeutics, Inc. | $343,000 | -14.9% | 79,193 | 0.0% | 0.04% | +15.8% | |
RPTX | Repare Therapeutics, Inc. | $259,000 | -19.6% | 12,276 | 0.0% | 0.03% | +10.0% | |
ALGS | Aligos Therapeutics, Inc. | $223,000 | -23.4% | 18,783 | 0.0% | 0.03% | +7.4% | |
OYST | Oyster Point Pharma, Inc. | $229,000 | +53.7% | 12,560 | 0.0% | 0.03% | +107.1% | |
EPZM | Epizyme, Inc. | $62,000 | -50.8% | 24,686 | 0.0% | 0.01% | -33.3% | |
NXTC | NextCure, Inc. | $60,000 | -11.8% | 10,044 | 0.0% | 0.01% | +33.3% | |
YMTX | Yumanity | $65,000 | -71.4% | 22,030 | 0.0% | 0.01% | -61.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
Trevena, Inc. | 25 | Q4 2021 | 1.2% |
Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
Zuora, Inc. | 21 | Q3 2023 | 3.4% |
Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
LendingClub Corp. | 18 | Q3 2019 | 11.9% |
Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
40-APP | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-26 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.